Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Kohlmann

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Plos One|October 15, 2016
Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic SyndromesMaría Abáigar, Cristina Robledo, Rocío Benito, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study GroupTorsten Haferlach, Alexander Kohlmann, Lothar Wieczorek, et al.
Blood|June 25, 2013
Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domainSimona Soverini, Caterina De Benedittis, K Machova Polakova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib)Maha Hussain, Claire Corcoran, Caroline Sibilla, et al.
Cell Stem Cell|April 8, 2014
Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unitHind Medyouf, Maximilian Mossner, Johann-Christoph Jann, et al.
British Journal of Haematology|June 25, 2008
An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephaseAlexander Kohlmann, Thomas J Kipps, Laura Z Rassenti, et al.
Plos One|December 3, 2015
A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic LeukemiaJosé Ángel Hernández, María Hernández-Sánchez, Ana Eugenia Rodríguez-Vicente, et al.
Blood|February 14, 2014
Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesisJulia Skokowa, Doris Steinemann, Jenny E Katsman-Kuipers, et al.
Journal of Hematology & Oncology|April 13, 2017
Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemiaMiguel Quijada-Álamo, María Hernández-Sánchez, Cristina Robledo, et al.
Blood|September 21, 2013
EZH2 mutations are frequent and represent an early event in follicular lymphomaCsaba Bödör, Vera Grossmann, Nikolay Popov, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Plos One|October 15, 2016
Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic SyndromesMaría Abáigar, Cristina Robledo, Rocío Benito, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study GroupTorsten Haferlach, Alexander Kohlmann, Lothar Wieczorek, et al.
Blood|June 25, 2013
Unraveling the complexity of tyrosine kinase inhibitor-resistant populations by ultra-deep sequencing of the BCR-ABL kinase domainSimona Soverini, Caterina De Benedittis, K Machova Polakova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2022
Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib)Maha Hussain, Claire Corcoran, Caroline Sibilla, et al.
Cell Stem Cell|April 8, 2014
Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unitHind Medyouf, Maximilian Mossner, Johann-Christoph Jann, et al.
British Journal of Haematology|June 25, 2008
An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephaseAlexander Kohlmann, Thomas J Kipps, Laura Z Rassenti, et al.
Plos One|December 3, 2015
A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic LeukemiaJosé Ángel Hernández, María Hernández-Sánchez, Ana Eugenia Rodríguez-Vicente, et al.
Blood|February 14, 2014
Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesisJulia Skokowa, Doris Steinemann, Jenny E Katsman-Kuipers, et al.
Journal of Hematology & Oncology|April 13, 2017
Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemiaMiguel Quijada-Álamo, María Hernández-Sánchez, Cristina Robledo, et al.
Blood|September 21, 2013
EZH2 mutations are frequent and represent an early event in follicular lymphomaCsaba Bödör, Vera Grossmann, Nikolay Popov, et al.
Pageof 11